about
C-reactive protein for diagnosing late-onset infection in newborn infantsNew means to assess neonatal inflammatory brain injuryDevelopment and maturation of the immune system in preterm neonates: results from a whole genome expression study.Lactoferrin for prevention of neonatal sepsis[Unifying criteria for late neonatal sepsis: proposal for an algorithm of diagnostic surveillance].Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) StudyChallenges in the diagnosis and management of neonatal sepsis.Rational development of guidelines for management of neonatal sepsis in developing countriesRandomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g.Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates.'Tweaking' the model for understanding and preventing maternal and neonatal morbidity and mortality in Low Income Countries: "inserting new ideas into a timeless wine skin".Adverse consequences of neonatal antibiotic exposureClonal Structure and Characterization of Staphylococcus aureus Strains from Invasive Infections in Paediatric Patients from South Poland: Association between Age, spa Types, Clonal Complexes, and Genetic Markers.Risk factors for infectious disease death among infants in the United StatesPhenotypic characterisation of coagulase-negative staphylococci isolated from blood cultures in newborn infants, with a special focus on Staphylococcus capitis.Effects of Placental Transfusion on Neonatal and 18 Month Outcomes in Preterm Infants: A Randomized Controlled Trial.Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.Surgical site infections in a longitudinal cohort of neonatal intensive care unit patients.Exchange Transfusion in the Treatment of Neonatal Septic Shock: A Ten-Year Experience in a Neonatal Intensive Care Unit.The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation.Plasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early Life.Immunological Defects in Neonatal Sepsis and Potential Therapeutic Approaches.Neonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune ResponsesTherapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.Impact of special patient populations on the pharmacokinetics of echinocandins.Group B Streptococcus causes severe sepsis in term neonates: 8 years experience of a major Chinese neonatal unit.Regulatory T cell frequencies are increased in preterm infants with clinical early-onset sepsis.Management of early-onset neonatal sepsis differs in the north and south of Scandinavia.Biomarkers for diagnosis of neonatal sepsis: a literature review.Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype.Lactoferrin concentration in breast milk of mothers of low-birth-weight newborns.[Late-onset neonatal sepsis in preterm infants with birth weight under 1.500 g].Clinical chorioamnionitis at term VI: acute chorioamnionitis and funisitis according to the presence or absence of microorganisms and inflammation in the amniotic cavity.Neonatal sepsis in a Nigerian private tertiary hospital: Bacterial isolates, risk factors, and antibiotic susceptibility patterns.Diagnostic accuracy of the ROCHE Septifast PCR system for the rapid detection of blood pathogens in neonatal sepsis-A prospective clinical trial.Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis.Nationwide survey of neonatal invasive fungal infection in Japan.Using newborn screening analytes to identify cases of neonatal sepsis.Vagus Nerve Stimulation for Treatment of Inflammation: Systematic Review of Animal Models and Clinical Studies.Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries.
P2860
Q24186059-C5B3AA43-1162-4067-867D-1A69367A92AEQ26786753-3DB6C547-D9EA-4D40-8A3E-41AC1575D3C0Q33758758-B31277EF-8050-4859-AE1D-5FE3B8B46011Q35042515-5373BB85-8C1F-4ED9-AB9A-7D699EB82EC3Q35058959-FE6D79D2-BA20-4027-BD61-CC4667A61685Q35105787-060065A1-B6E6-4288-A8C3-8E581B57674AQ35221313-B7AAB1C8-93D2-401B-BF16-F62B734700BCQ35580540-939B572F-1E2B-4692-AC44-5957FD09F06EQ35619568-5F5CB87A-A509-4958-922E-49CB71FAD2FAQ35882560-D5AC3C6E-3BBE-4C40-B08E-E55441E31F16Q35904292-A3B93712-5C34-4042-AD96-0A2729170D5AQ35926313-C68A97D8-B6A4-4C08-93A1-D2F5D76ED367Q35962986-38B135B9-2BDF-4A40-BCAB-4EC5990F6D38Q36192481-FE9C7310-705D-4380-B181-C86C8A499651Q36410012-1864814A-109E-443D-815A-98C2F5E9D77BQ36421386-8C3FF2DD-06E2-4BD6-8EB2-7765906BE543Q36676402-1B2E85A3-ECE1-4C84-97AB-C1F331CACB9FQ36730902-5C3CDDF2-E64B-4CA7-81FE-906B5A3E5859Q36939244-BAF2AD77-D348-48BD-B6AA-59FC7C2F7BA7Q37424171-322F6347-A529-4532-A4DE-069A21068129Q37604131-9062B6B2-907D-4B80-97A8-2BAA8CB6541EQ37627158-027641DD-5D70-4ACB-9B74-1A304F2975D9Q37683149-5A62EA14-1B77-475E-9256-0216CE0969D8Q38353420-A092B56E-12E0-4812-93B2-B550DB2EF86AQ38462784-02FA5CC0-6A27-4A41-9600-F549B715326DQ38754954-52D36A23-8E53-42F1-816C-DEA67F5367E1Q38869272-3BE9F8A0-ECE0-4E70-B4B3-7127D757F00AQ39115900-5BA6E5F4-04E2-4BB6-82BD-DC87557364B2Q39252687-83644BDC-A55C-48F3-84FA-6F68B57C8D6BQ40229629-EA95B821-416E-455A-9BB3-1CBEC005CEB4Q40357306-0D70DA0A-6233-40A5-A616-50DBD565EA9EQ40843637-3D9D387E-A418-4681-B5F1-A6CB8168CDA3Q41008958-64DC1BF4-3EEA-4306-BB3B-19B2C32C0BEFQ41877097-4A64D877-F13E-442F-90AD-02884C796735Q44142232-DB28E19E-5E09-4FEB-AC0D-254AE5ACA0E4Q45397507-9C847165-6D07-4CF1-A996-94DFFCDC4C4DQ46271669-45658CF3-01F8-42D9-AAD7-BAD3E0CD40E4Q47094991-0808720F-4A3F-4369-A273-ACD3A7A622AAQ47135796-E3B62E4D-C0FF-4417-A9CE-8D22F1271E3EQ48163160-035BCFEF-DF9A-4225-B202-189CC7BDCE9C
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Neonatal sepsis: progress towards improved outcomes.
@ast
Neonatal sepsis: progress towards improved outcomes.
@en
Neonatal sepsis: progress towards improved outcomes.
@nl
type
label
Neonatal sepsis: progress towards improved outcomes.
@ast
Neonatal sepsis: progress towards improved outcomes.
@en
Neonatal sepsis: progress towards improved outcomes.
@nl
prefLabel
Neonatal sepsis: progress towards improved outcomes.
@ast
Neonatal sepsis: progress towards improved outcomes.
@en
Neonatal sepsis: progress towards improved outcomes.
@nl
P1433
P1476
Neonatal sepsis: progress towards improved outcomes.
@en
P2093
Andi L Shane
Barbara J Stoll
P304
P356
10.1016/J.JINF.2013.09.011
P478
68 Suppl 1
P577
2013-10-18T00:00:00Z